Clinical Trials Directory

Trials / Unknown

UnknownNCT05366504

LiST Plus PRP Injection Therapy vs LiST Monotherapy for ED Treatment

Is Combined Low Intensity Shockwave Therapy (LiST) Plus Platelet-rich Plasma (PRP) Injection Therapy Better Than LiST Monotherapy for the Improvement of Erectile Function? a Double-blind, Randomized, Placebo-controlled Clinical Trial

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Institute for the Study of Urological Diseases, Greece · Academic / Other
Sex
Male
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

We designed a double blind randomized sham-controlled trial in order to investigate and compare the treatment efficacy of LiST plus PRP intracorporeal injection vs LiST plus placebo (normal saline intracorporeal injection) in men with moderate and mild to moderate vasculogenic ED, as measured by IIEF-EF.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTLiST + PRP intracorporeal injection12 LiST sessions (2 sessions per week) plus PRP (2 intracorporeal injections 3 weeks apart, after the 1st and the 7th LiST sessions) ( 30 patients).
COMBINATION_PRODUCTLiST + Placebo(normal saline intracorporeal injection)All subjects of this group will receive 12 sessions (V3-V14) of LiST with session frequency 2/week and 2 normal saline injections with 3 weeks treatment interval (V3 and V9), 10 ml of normal saline will be injected at each session.

Timeline

Start date
2022-09-01
Primary completion
2023-12-01
Completion
2024-03-01
First posted
2022-05-09
Last updated
2022-05-09

Source: ClinicalTrials.gov record NCT05366504. Inclusion in this directory is not an endorsement.